DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results.

Authors: Martin Wermke, Juergen Alt, Farastuk Bozorgmehr, Florian Fuchs, Pauline du Rusquec, Anas Gazzah, Sean Dulloo, Ewa Kalinka, Aman Chauhan, Anna Mosikian, Sabine Kirner, Dian Yang, Cyrus Sayehli

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.8094

Source: Full article

---

Abstract

8094